Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.

E. Parmee,H. Ok,M. Candelore,L. Tota,L. Deng,C. Strader,M. Wyvratt,M. Fisher,A. Weber
IF: 2.94
Bioorganic & Medicinal Chemistry Letters
Abstract:A study of 4-acylaminobenzenesulfonamides in a cloned human beta 3 adrenergic receptor assay resulted in the discovery of n-hexylurea, L-755,507 (22). This 0.43 nM beta 3 agonist, which is > 440-fold selective over both beta 1 and beta 2 binding, is among the most potent human beta 3 agonists reported to date.
What problem does this paper attempt to address?